Me. Rev. Stat. tit. 24-A, § 7753 (2025)
1. Interference with acquisition or delivery of 340B drugs prohibited A manufacturer or its agent may not deny, restrict, prohibit or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B contract pharmacy on behalf of a 340B entity unless receipt of that 340B drug is prohibited by the United States Department of Health and Human Services.
[PL 2025, c. 388, Pt. P, §5 (NEW).]
2. Submission of claims or utilization data prohibited A manufacturer or its agent may not, either directly or indirectly, require a 340B entity to submit any claims or utilization data as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity unless the claims or utilization data sharing is required by the United States Department of Health and Human Services.
[PL 2025, c. 388, Pt. P, §5 (NEW).]
3. Other interference prohibited A manufacturer may not otherwise interfere directly or indirectly with a 340B entity unless expressly authorized by the United States Department of Health and Human Services.
[PL 2025, c. 388, Pt. P, §5 (NEW).]
PL 2025, c. 388, Pt. P, §5 (NEW).